English  丨  中文
About Us
Sirnaomics is leveraging an unsurpassed level of knowledge and experience in RNA interference (RNAi) technology and forging a path to high value creation with exciting clinical product development programs in multiple therapeutic areas. Sirnaomics, Inc. was established in 2007 by a group of leading scientists from top US pharmaceutical companies. 

Our management team has combined over 100 years experience in the biopharmaceutical industries with special expertise in RNAi and delivery system technologies. We have partnered with NIH, NAVY MRC, Johns Hopkins, Duke, University of Maryland and Penn State University. This work has advanced our product development and preclinical programs and we are now ready to move forward with our clinical development strategy.  The vast experience of our scientific and management teams ensures that our therapeutics are developed with the highest quality of scientific validity and supported by a solid intellectual property portfolio. We feel this gives us a significant advantage in both the safety and efficacy of our therapeutics as we move forward and execute our clinical programs in US, EU, and China. 

Sirnaomics, Inc.

Gaithersburg, Maryland

U.S.A.